Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00822172 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Cilostazol in Combination With L-Carnitine
A Phase 4 study, sponsored by Colorado Prevention Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 164
- Enrollment target
NCT00822172: Completed Phase 4 study, sponsored by Colorado Prevention Center.
NCT00822172 is a Phase 4 study that has completed, run by Colorado Prevention Center. The registered enrollment target is 164 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00822172, a Phase 4 study, has completed, sponsored by Colorado Prevention Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this study is to see how safe and effective L carnitine taken with cilostazol is compared to placebo taken with cilostazol for people with intermittent claudication. A second purpose of the study is to see if L-carnitine is absorbed into the blood stream.
Primary Outcome
Subjects were asked to complete a standardized exercise treadmill test using a modified Gardner protocol. Subjects walked on the treadmill until they were physically unable to walk further either as a result of their peripheral artery disease (PAD) symptoms or other non-PAD symptoms. This maximum time walked is referred to as the peak walking time (PWT) and reported in minutes/seconds. The exercise treadmill test was conducted at Screening, Baseline, Day 90, and Day 180 visits. The log transform
Interventions
- DRUG cilostazol
- DIETARY_SUPPLEMENT Levocarnitine tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
What the finished NCT00822172 record still lists
NCT00822172 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which cilostazol is the first listed.
NCT00822172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00822172 about?
NCT00822172 is a clinical study titled "Evaluation of Cilostazol in Combination With L-Carnitine". The purpose of this study is to see how safe and effective L carnitine taken with cilostazol is compared to placebo taken with cilostazol for people with intermittent claudication. A second purpose of the study is to see if L-carnitine is absorbed into the blood stream.
What is the current status of trial NCT00822172?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 164 participants. The study started on 2008-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00822172?
The interventions under investigation include: cilostazol (DRUG), Levocarnitine tartrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00822172?
This trial is sponsored by Colorado Prevention Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00822172's enrollment target sits among peer trials
164 496th of 2000 higher than 1,500 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia